$429.52
-16.39-3.68%
al cierre: -
$432.05
2.530.59%
After hour: Nov 7, 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Tesla Inc tiene un precio objetivo de consenso de $377.45 basado en las calificaciones de 30 analistas. El máximo es $600, emitido por Wedbush el noviembre 7, 2025. El mínimo es $19.05, emitido por GLJ Research el octubre 22, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Wedbush, Wedbush y B of A Securities el noviembre 7, 2025, noviembre 5, 2025 y octubre 29, 2025, respectivamente. Con un precio objetivo promedio de $557 entre Wedbush, Wedbush y B of A Securities, hay una 28.92% upside implícita para Tesla Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Wedbush
B of A Securities
Freedom Capital Markets
RBC Capital
Truist Securities
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Tesla
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/07/2025 | 38.87% | Wedbush | $600 → $600 | Reiterates | Outperform → Outperform | |||
11/05/2025 | 38.87% | Wedbush | $600 → $600 | Reiterates | Outperform → Outperform | |||
10/29/2025 | 9.02% | B of A Securities | $341 → $471 | Maintains | Neutral | |||
10/24/2025 | -6.03% | Freedom Capital Markets | $338 → $406 | Upgrade | Sell → Hold | |||
10/23/2025 | 15.73% | RBC Capital | $500 → $500 | Reiterates | Outperform → Outperform | |||
10/23/2025 | -6.03% | Truist Securities | $280 → $406 | Maintains | Hold | |||
10/23/2025 | 11.56% | Canaccord Genuity | $490 → $482 | Maintains | Buy | |||
10/23/2025 | 18.04% | Cantor Fitzgerald | $355 → $510 | Maintains | Overweight | |||
10/23/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
10/22/2025 | -95.59% | GLJ Research | $19.05 → $19.05 | Reiterates | Sell → Sell | |||
10/21/2025 | -17.83% | Cantor Fitzgerald | $355 → $355 | Reiterates | Overweight → Overweight | |||
10/20/2025 | 38.87% | Wedbush | $600 → $600 | Reiterates | Outperform → Outperform | |||
10/17/2025 | -18.99% | Barclays | $275 → $350 | Maintains | Equal-Weight | |||
10/16/2025 | -18.99% | Barclays | $275 → $350 | Maintains | Equal-Weight | |||
10/13/2025 | 20.36% | Melius Research | → $520 | Initiates | → Buy | |||
10/13/2025 | -30.56% | Evercore ISI Group | $235 → $300 | Maintains | In-Line | |||
10/08/2025 | 11.79% | Stifel | $440 → $483 | Maintains | Buy | |||
10/06/2025 | -42.83% | UBS | $215 → $247 | Maintains | Sell | |||
10/03/2025 | 13.41% | Canaccord Genuity | $490 → $490 | Maintains | Buy | |||
10/03/2025 | -17.83% | Cantor Fitzgerald | $355 → $355 | Reiterates | Overweight → Overweight | |||
10/02/2025 | -5.1% | Morgan Stanley | $410 → $410 | Reiterates | Overweight → Overweight | |||
09/30/2025 | 13.41% | Canaccord Genuity | $333 → $490 | Maintains | Buy | |||
09/26/2025 | 0.68% | Deutsche Bank | $345 → $435 | Maintains | Buy | |||
09/26/2025 | 38.87% | Wedbush | $500 → $600 | Maintains | Outperform | |||
09/23/2025 | 4.15% | Mizuho | $375 → $450 | Maintains | Outperform | |||
09/22/2025 | 15.73% | Piper Sandler | $400 → $500 | Maintains | Overweight | |||
09/19/2025 | 26.84% | Baird | $320 → $548 | Upgrade | Neutral → Outperform | |||
09/18/2025 | -8.58% | Goldman Sachs | $300 → $395 | Maintains | Neutral | |||
09/15/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
08/04/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/29/2025 | -24.78% | RBC Capital | $319 → $325 | Maintains | Outperform | |||
07/25/2025 | -19.22% | China Renaissance | — | → $349 | Downgrade | Buy → Hold | ||
07/24/2025 | -95.59% | GLJ Research | $19.05 → $19.05 | Reiterates | Sell → Sell | |||
07/24/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/24/2025 | -17.83% | Cantor Fitzgerald | $355 → $355 | Reiterates | Overweight → Overweight | |||
07/24/2025 | — | Needham | — | Maintains | Hold | |||
07/23/2025 | -59.5% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
07/22/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/21/2025 | -21.07% | B of A Securities | $305 → $341 | Maintains | Neutral | |||
07/11/2025 | -34.04% | Goldman Sachs | $315 → $285 | Maintains | Neutral | |||
07/08/2025 | -13.2% | Mizuho | $390 → $375 | Maintains | Outperform | |||
07/08/2025 | -59.5% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
07/08/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/07/2025 | — | William Blair | — | Downgrade | Outperform → Market Perform | |||
07/03/2025 | -27.09% | Goldman Sachs | $285 → $315 | Maintains | Neutral | |||
07/03/2025 | -72.23% | HSBC | $120 → $120 | Reiterates | Reduce → Reduce | |||
07/01/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/30/2025 | -29.87% | Canaccord Genuity | $303 → $303 | Maintains | Buy | |||
06/26/2025 | 9.94% | Benchmark | $350 → $475 | Maintains | Buy | |||
06/23/2025 | -59.5% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
06/23/2025 | -50.24% | UBS | $190 → $215 | Maintains | Sell | |||
06/23/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/20/2025 | 15.73% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/11/2025 | -7.42% | Piper Sandler | $400 → $400 | Reiterates | Overweight → Overweight | |||
06/09/2025 | -5.1% | Morgan Stanley | $410 → $410 | Reiterates | Overweight → Overweight | |||
06/09/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
06/09/2025 | -25.93% | Baird | $320 → $320 | Downgrade | Outperform → Neutral | |||
06/06/2025 | -34.04% | Goldman Sachs | $295 → $285 | Maintains | Neutral | |||
05/23/2025 | 15.73% | Wedbush | $350 → $500 | Maintains | Outperform | |||
05/16/2025 | -9.73% | Mizuho | $325 → $390 | Maintains | Outperform | |||
05/06/2025 | -45.61% | Goldman Sachs | $275 → $235 | Reiterates | Neutral → Neutral | |||
05/01/2025 | -18.99% | Wedbush | $350 → $350 | Reiterates | Outperform → Outperform | |||
04/24/2025 | -60.65% | Guggenheim | $170 → $170 | Reiterates | Sell → Sell | |||
04/24/2025 | 4.15% | Stifel | $455 → $450 | Maintains | Buy | |||
04/23/2025 | -18.99% | Benchmark | $350 → $350 | Reiterates | Buy → Buy | |||
04/23/2025 | -24.78% | Mizuho | $375 → $325 | Maintains | Outperform | |||
04/23/2025 | -8.58% | Roth MKM | $450 → $395 | Maintains | Buy | |||
04/23/2025 | -28.94% | RBC Capital | $314 → $307 | Maintains | Outperform | |||
04/23/2025 | -73.38% | JP Morgan | $120 → $115 | Maintains | Underweight | |||
04/23/2025 | -17.83% | Cantor Fitzgerald | $425 → $355 | Maintains | Overweight | |||
04/23/2025 | -29.87% | Canaccord Genuity | $404 → $303 | Maintains | Buy | |||
04/23/2025 | -18.99% | Wedbush | $315 → $350 | Maintains | Outperform | |||
04/23/2025 | -25.93% | Baird | $370 → $320 | Maintains | Outperform | |||
04/23/2025 | -95.59% | GLJ Research | $24.86 → $19.05 | Maintains | Sell | |||
04/23/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/22/2025 | -29.41% | B of A Securities | $380 → $305 | Maintains | Neutral | |||
04/17/2025 | -36.35% | Barclays | $325 → $275 | Maintains | Equal-Weight | |||
04/16/2025 | -7.42% | Piper Sandler | $450 → $400 | Maintains | Overweight | |||
04/10/2025 | -56.02% | UBS | $225 → $190 | Maintains | Sell | |||
04/10/2025 | -13.2% | Mizuho | $430 → $375 | Maintains | Outperform | |||
04/09/2025 | -18.99% | Benchmark | $475 → $350 | Maintains | Buy | |||
04/07/2025 | -27.09% | Wedbush | $550 → $315 | Maintains | Outperform | |||
04/03/2025 | -36.35% | Goldman Sachs | $320 → $275 | Maintains | Neutral | |||
04/03/2025 | -35.19% | Truist Securities | $373 → $280 | Maintains | Hold | |||
04/03/2025 | -1.63% | Cantor Fitzgerald | $425 → $425 | Reiterates | Overweight → Overweight | |||
03/31/2025 | 5.31% | Stifel | $474 → $455 | Maintains | Buy | |||
03/28/2025 | -20.15% | Deutsche Bank | $420 → $345 | Maintains | Buy | |||
03/27/2025 | 27.3% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/21/2025 | 27.3% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/21/2025 | -5.1% | Morgan Stanley | $430 → $410 | Maintains | Overweight | |||
03/20/2025 | 27.3% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/20/2025 | 4.15% | Piper Sandler | $500 → $450 | Maintains | Overweight | |||
03/19/2025 | -1.63% | Cantor Fitzgerald | $425 → $425 | Upgrade | Neutral → Overweight | |||
03/18/2025 | -25.93% | RBC Capital | $440 → $320 | Maintains | Outperform | |||
03/17/2025 | -6.49% | Canaccord Genuity | $404 → $404 | Maintains | Buy | |||
03/17/2025 | -0.47% | Mizuho | $515 → $430 | Maintains | Outperform | |||
03/14/2025 | -69.91% | Wells Fargo | $135 → $130 | Maintains | Underweight | |||
03/12/2025 | -72.23% | JP Morgan | $135 → $120 | Maintains | Underweight | |||
03/12/2025 | -60.65% | Guggenheim | $175 → $170 | Maintains | Sell | |||
03/11/2025 | 27.3% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Tesla (TSLA)?
El último precio objetivo de Tesla (NASDAQ:TSLA) fue comunicado por Wedbush el noviembre 7, 2025. La firma de analistas fijó un precio objetivo para $600.00 que espera TSLA a rise dentro de 12 meses (un posible 38.87% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Tesla (TSLA)?
La última calificación de analistas para Tesla (NASDAQ:TSLA) fue proporcionada por Wedbush, y Tesla reiterado su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Tesla (TSLA)?
La última revisión al alza de Tesla Inc se produjo en octubre 24, 2025, cuando Freedom Capital Markets elevó su precio objetivo a $406. Freedom Capital Markets anteriormente tenía a sell para Tesla Inc.
¿Cuándo fue la última revisión a la baja de Tesla (TSLA)?
La última revisión a la baja de Tesla Inc se produjo en julio 25, 2025, cuando China Renaissance cambió su precio objetivo de N/A a $349 para Tesla Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Tesla (TSLA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Tesla, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Tesla se registró el noviembre 7, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 7, 2026.
¿Es correcta la calificación de los analistas sobre Tesla (TSLA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Tesla (TSLA) fue un reiterado con un precio objetivo de $600.00 a $600.00. El precio actual al que cotiza Tesla (TSLA) es de $432.05, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.